Aclid

We're hosting a deep dive with #RTXBBN on the U.S. government’s “Framework for Nucleic Acid Synthesis Screening”. Learn more about the new screening requirements for providers of all DNA/RNA including CROs, CDMOs, and gene and oligo synthesis services. Hear from thought leaders from Battelle, International Biosecurity and Biosafety Initiative for Science (IBBIS), National Institute of Standards and Technology (NIST), National Security Council, The White House and Twist Bioscience. Register here: https://lnkd.in/eqbikv42

🗞️ 2048 Ventures Portfolio Company News: The US Is Cracking Down on Synthetic DNA https://lnkd.in/gnx4tpZH Aclid // 2048 Ventures // #startups // #VC

Today, the White House issued new screening requirements for providers of synthetic DNA and RNA. If you're interested in a quick summary of the updates, we wrote about it here: https://lnkd.in/eUMePMWN

We're hosting a night of apps and drinks with NinthBio on May 6th from 6:00 pm to 8:00 pm. Join us for the 2024 SynBioBeta kickoff! Register today! https://lu.ma/tn1q7l9i

🔬 Synthesis and Cloning Providers — Screening Is a Competitive Advantage The White House is issuing new legislation that mandates screening certification for vendors working with government agencies, academic institutions, and federal contractors. ➡️ Leading providers like Integrated DNA Technologies, Thermo Fisher Scientific, and Twist Bioscience are already using screening to get ahead of the curve. 🦖 Don't risk disruptions to your customer contracts and workflows - start getting certified now. 📚 To learn more about the new standards, the implications and opportunities, and how to get started with an automated screening tool like Aclid see the link below: 📝 https://lnkd.in/eUMePMWN

We'll be at SynBioBeta this year talking about all things biosecurity. We hope to see some of you there!

We're #hiring a new Software Engineer in New York, New York. Apply today or share this post with your network.

We're grateful for the opportunity to share our story and work with the Bits in Bio community!

Aclid Secures $3.3 Million Seed Funding Round to Advance Biosecurity and Compliance We are pleased to announce that we just closed an oversubscribed seed financing of $3.3 million, led by 2048 Ventures and IA Ventures. Aclid is building a simple-to-deploy, automated platform that keeps security teams focused on the most important risks while staying up-to-date with the latest regulations and research. The gene synthesis providers using our solution already spend less time reviewing orders and managing compliance. By automating the most time-consuming parts of the process, customer verifications and follow-up, we’re making it easy for providers to stay compliant. Thanks to 2048 Ventures and IA Ventures for supporting us on our journey to help secure gene and oligo synthesis - the foundation of the bioeconomy. https://lnkd.in/e2W3_MmQ

Aclid Secures $3.3 Million Seed Funding Round to Advance Biosecurity and Compliance We are pleased to announce that we just closed an oversubscribed seed financing of $3.3 million, led by 2048 Ventures and IA Ventures. Aclid is building a simple-to-deploy, automated platform that keeps security teams focused on the most important risks while staying up-to-date with the latest regulations and research. The gene synthesis providers using our solution already spend less time reviewing orders and managing compliance. By automating the most time-consuming parts of the process, customer verifications and follow-up, we’re making it easy for providers to stay compliant. Thanks to 2048 Ventures and IA Ventures for supporting us on our journey to help secure gene and oligo synthesis - the foundation of the bioeconomy. https://lnkd.in/e2W3_MmQ